| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.7M | +245.3% |
| R&D Expense | $67.2M | -9.6% |
| SG&A Expense | $19.1M | -1.2% |
| Operating Income | -$80.6M | +12.4% |
| Income Tax | $0 | — |
| Net Income | -$75.4M | +13.6% |
| EPS (Basic) | -$1.49 | +27.3% |
| EPS (Diluted) | -$1.49 | +27.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $57.4M | -54.3% |
| Current Assets | $79.2M | -44.7% |
| Total Assets | $91.0M | -42.9% |
| Current Liabilities | $8.9M | -22.1% |
| Total Liabilities | $11.4M | -23.1% |
| Stockholders' Equity | $79.6M | -45.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$60.5M | +25.5% |
| Capital Expenditures | $59K | -85.5% |
| Investing Cash Flow | -$8.5M | -107.7% |
| Financing Cash Flow | $787K | -98.4% |
| Free Cash Flow | -$60.6M | +25.8% |